Sensorion to Begin Patient Enrollment for Safety Study of Vertigo Drug, Seliforant
MONTPELLIER, FRANCE — Biotech firm Sensorion announced the initiation of patient enrollment in a Phase 2a study (SENS-111-202) to confirm the absence of certain side effects commonly experienced with meclizine (specifically, anticholinergic side effects like sedation and memory loss) during an evoked vestibular imbalance. SENS-111-202 is a randomized, double-blind, double-dummy, placebo-controlled, cross-over trial in patients designed…
Read More
Researchers Discover New Form of Vertigo That Can be Treated
As many audiologists know, vertigo has a myriad of causes and the treatment process can be complex and time-consuming. Researchers in South Korea, however, have identified a new type of vertigo that may be effectively treated with medication. A study, published online last week in the journal Neurology identified what they consider a new condition,…
Read More
New Best Practice Guidelines Issued for BPPV, One of the Most Common Causes of Vertigo
ALEXANDRIA, VIRGINIA — On March 1st, the American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) published an updated clinical practice guideline for healthcare providers on benign paroxysmal positional vertigo (BPPV). The updated guideline, Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo, provides evidence-based recommendations to healthcare providers on diagnosis and treatment of BPPV. Additionally, the…
Read More
Writer Recounts Her Struggles with Superior Canal Dehiscence Syndrome
Superior Canal Dehiscence Syndrome (SCDS) is a balance condition that involves a tear in the uppermost semicircular canal. According to the literature, the condition was first described and defined in 1995 by clinicians at Johns Hopkins School of Medicine. It is believed to occur because the bony surface of the canal did not grow to…
Read More
Fall Risk Increases Above Age 40
Many audiologists who work with patients experiencing equilibrium problems are keenly aware of the relationship between aging and balance. This observation was recently confirmed in a study published online in Frontiers in Neurology. This study, conducted by researchers at Massachusetts Eye and Ear, found vestibular thresholds begin to double every 10 years above the age…
Read More
Sound Pharmaceuticals Hires Two New Executives to Speed Development of Meniere’s Drug
SEATTLE, WASHINGTON — Sound Pharmaceuticals, a Seattle-based biotech firm, announced this week that it has hired two senior executives. Paul Hoskins, appointed to the position of Senior Director of Clinical Operations and G. Michael Wall, appointed to the position of Senior Director of Pharmaceutical Development. The new executives join the company with substantial backgrounds in the pharmaceutical industry. Sound Pharmaceuticals hopes that…
Read More
Wind Turbines: Noise and Health
Editor’s Note: Today Hearing News Watch brings readers a special post, written by contributors Jerry Punch, PhD and Richard James, INCE, discussing their new article published at the HHTM Journal. By Jerry Punch, PhD and Richard James, INCE, BME We authored an earlier three-part series of articles on the topic of the effects of wind turbine…
Read More
Samsung’s New Entrim Headset Tricks Brain by Sending Electrical Signals to the Inner Ear
AUSTIN, TEXAS — Samsung has unveiled yet another set of technologies developed by its secretive C-Lab, this time at the SXSW festival in Texas. One of the most interesting of its latest projects is a new headset called Entrim 4D, which enhances the experience of virtual reality (VR) by using electrical stimulation of the inner…
Read More
No More Dizzy Pills? Device to Treat Motion Sickness likely Available “Within 5 to 10 Years”
LONDON, UNITED KINGDOM – Researchers at the Imperial College of London (ICL) are developing an effective new treatment for motion sickness, which they say could become available over the counter sometime in the next five to ten years. Instead of developing a pharmaceutical treatment for motion sickness and dizziness, researchers at ICL have instead focused on…
Read More